Type 2 polyglandular autoimmune disease (Schmidt's syndrome).
Data on clinical, genetic, and immunological aspects of sixty patients with type 2 polyglandular autoimmune disease (PGAD) are presented. The literature on this is reviewed and discussed.
Betterle
C
C
Institute of Semeiotica Medica, Chair of Clinical Immunology and Allergy, University of Padova, Italy.
Volpato
M
M
Greggio
A N
AN
Presotto
F
F
D000224:Addison Disease / Q000209:etiology / Q000276:immunology / Q000503:physiopathology; D000293:Adolescent; D000328:Adult; D017668:Age of Onset; D000368:Aged; D000818:Animals; D001323:Autoantibodies / Q000276:immunology; D001324:Autoantigens / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D016884:Polyendocrinopathies, Autoimmune / Q000145:classification / Q000453:epidemiology / Q000276:immunology / Q000503:physiopathology; D015995:Prevalence
D001323:Autoantibodies; D001324:Autoantigens